rianjs.net

More than a decade later, Halpern is now an associate director of substance abuse research at Harvard University's McLean Hospital and is at the forefront of a revival of research into psychedelic medicine. He recently received approval from the US Food and Drug Administration (FDA) to give late-stage cancer patients the psychedelic drug MDMA, also known as ecstasy. He is also laying the groundwork for testing LSD as a treatment for dreaded super-migraines known as cluster headaches.

And Halpern is not alone. Clinical trials of psychedelic drugs are planned or under way at numerous centres around the world for conditions ranging from anxiety to alcoholism. It may not be long before doctors are legally prescribing hallucinogens for the first time in decades. "There are medicines here that have been overlooked, that are fundamentally valuable," says Halpern.

I wonder if we'll study them in coming years… anyone care to comment? Personally, I'd like to see drugs re-evaluated despite their public stigma. (*cough*marijuana*cough*)

The article goes into quite a bit more detail about the whole thing, and how psychedelic drugs were "discovered."

From New Scientist.

Trackback This Post | Subscribe to the comments through RSS Feed